Physician profile
Sonia E Erickson
NPI 1619996105
$2,299.43
in general payments reported to CMS, 2019-2025
23 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $333 · 2021: $415 · 2022: $356 · 2023: $275 · 2024: $231 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $708.19 | 2019-2025 | Collagenase Santyl |
| Stryker Corporation | $209.20 | 2024-2025 | Augment Injectable |
| Horizon Therapeutics Plc | $175.78 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $173.95 | 2019-2021 | |
| Amgen INC. | $167.48 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $125.69 | 2019-2023 | Puraply |
| Nevro Corp. | $108.63 | 2022 | |
| Orthofix Medical, INC. | $88.98 | 2021-2024 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $88.42 | 2020-2023 | Jublia |
| Alfasigma USA, INC. | $78.73 | 2021-2022 | |
| Mimedx Group, INC. | $48.63 | 2024 | |
| Abbott Laboratories | $48.53 | 2021 | |
| Mayne Pharma Commercial LLC | $48.52 | 2021 | |
| Bioventus LLC | $47.69 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Ibsa Pharma INC. | $29.16 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $25.76 | 2020 | |
| Melinta Therapeutics, LLC | $24.93 | 2019 | |
| Abbvie INC. | $23.46 | 2021 | |
| Treace Medical Concepts, INC. | $22.72 | 2023 | |
| Pfizer INC. | $16.32 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2020 | |
| Integra Lifesciences Corporation | $11.73 | 2019 | |
| Zyla Life Sciences, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.